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 Proper protein folding is essential for cell function, as misfolding leads to cell 
stress and cytotoxicity.  Misfolded proteins are associated with several serious diseases 
in humans such as Parkinson’s and Alzheimer’s diseases.  The posttranslational 
modifier SUMO has been implicated in several of these diseases, including cystic 
fibrosis, amyotrophic lateral sclerosis, and other neurodegenerative diseases.  However, 
the mechanism by which SUMO affects protein folding and stress response is not well 
understood.  To address this question, we investigated a SUMO mutant that is sensitive 
to canavanine, an arginine analog that induces protein misfolding.  We characterized 
this mutant as deficient in binding to proteins containing SUMO-interacting motifs 
(SIMs) and hypothesized that a high-copy suppressor screen would identify proteins that 
function downstream of SUMO in the protein stress response. We found that San1, a 
ubiquitin E3 ligase involved in nuclear protein quality control, can suppress the 
sensitivity of our mutant to canavanine.  Interestingly, the RING domain required for E3 
ligase activity is not necessary for suppression, but the unstructured N-terminus of San1 
is both necessary and sufficient for suppression.  The N-terminus has a chaperone-like 
function, binding to unstructured, misfolded proteins.  Our findings suggest that 
sumoylation may either play a similar role and promote proper protein folding, or 
function to prevent the accumulation of toxic misfolded proteins in the cell. 
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 Posttranslational protein modifications, including phosphorylation, acetylation, 
and ubiquitination function to regulate nearly all cellular processes.  These 
modifications affect protein function by controlling stability, localization, and 
interactions with other proteins.  Posttranslational modifications often undergo shifts 
and changes between sets of proteins when cells encounter a new environment.  
Changes in the overall landscape of these modifications are associated with cellular 
stress response pathways, including oxidative stress, genotoxic stress, and protein 
misfolding stress.  By studying posttranslational modifications during cell stress, we can 
learn more about how the cell reacts to stress and what goes wrong in diseases 
associated with cell stress such as diabetes (1), cancer (2), and neurodegenerative 
diseases (3). 
1.1 The SUMO Pathway 
The Small Ubiquitin-related MOdifier, or SUMO, is a prominent 
posttranslational modification in the cell.  SUMO is a small, 100 kD peptide with one 
isoform in invertebrates and four isoforms in vertebrates.  In all organisms, SUMO is 
conjugated to other proteins through an E1 activating, E2 conjugating, and E3 ligating 
enzyme cascade (4, 5, 6).  In this cascade, there is only one E1 enzyme, called Aos1/
Uba2 in yeast, and a single E2 enzyme, called Ubc9 in yeast, however there are 
numerous E3 ligases which are thought to have varying specificity to the many SUMO 
substrates.  The consensus site for SUMO conjugation is ψKXE, where ψ is a large 
hydrophobic residue, K is the lysine of SUMO that is conjugated to substrates, X is any 




motif (SIM) consists of an essential hydrophobic core that is often juxtaposed with a 
cluster of acidic residues (8).  SUMO conjugation is reversible, with sentrin-specific 
proteases (SENPs) deconjugating SUMO from its substrates when it is no longer 
required (9).  SUMO conjugation and deconjugation regulate many cellular processes, 
including mitosis, nuclear transport, and DNA repair (10). 
1.2 SUMO in Cellular Stress Response 
SUMO has been implicated in the cellular response to many types of stresses, 
including hypoxic stress (11), genotoxic stress (12), and protein misfolding stress (3).  
Each of these types of stress is a causative factor in one or more human diseases.  
Hibernation and hypothermia in ground squirrels has been used by Lee et al. as a model 
for ischemia, a lack of oxygen evident in cells during heart attacks and kidney failure.  
While these animals are in hibernation, there is a strong increase in sumoylation in 
Figure 1: The SUMO Conjugation and Deconjugation Pathway.  SUMO is 
conjugated by an E1, E2, E3 enzyme cascade to its substrates, then deconjugated by 
isopeptidases known as sentrin-specific proteases, or SENPs. 
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brain, liver, and kidney cells (13).   This increase is thought to be protective, as siRNAs 
which inhibit global sumoylation are associated with increased apoptosis during hypoxic 
stress (14).  Additionally, during renal ischemia, there is a strong increase in high-
molecular-weight conjugates of SUMO which correlates with increased cell survival 
(15).   
Genotoxic stress is also very dangerous to cells; DNA damage and misregulation 
of the repair pathways are often involved in the formation of cancer.  BRCA1, the gene 
commonly found mutated in breast cancer, is a ubiquitin ligase that localizes to DNA 
damage sites.  BRCA1 modification by SUMO is required for its proper function at 
DNA damage sites in response to genotoxic stress (12).  SUMO and the E2 enzyme 
Ubc9 are also generally required for nuclear integrity.  Lack of Ubc9 in mice causes 
embryonic lethality due to chromosomal defects and alterations to nuclear organization 
such as disassembled nucleoli, misshapen nuclei, and mislocalized RanGAP1 and Ran 
(16). 
1.3 SUMO in Protein Misfolding Stress 
Many human diseases are caused by misfolded proteins, including cystic fibrosis 
(17, 18), amyotrophic lateral sclerosis (ALS) (19), Parkinson’s disease (20), and other 
neurodegenerative disorders (3).  SUMO has been found to associate with many of the 
causative misfolded proteins.  The most common mutation causing cystic fibrosis is a 
phenylalanine deletion at amino acid 508 in the cystic fibrosis transmembrane 
conductance receptor (CFTR) (17, 18).  This mutant CFTR associates with heat shock 
protein 27, which interacts with Ubc9 to selectively sumoylate the misfolded protein 
leading to proteasomal degradation via the SUMO targeted ubiquitin ligase RNF4 (17, 
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18).   
ALS is characterized by the progressive degeneration of motor neurons in both 
the spinal cord and the brain, and one feature of this disease is the aggregation of 
proteins that form inclusion bodies containing both ubiquitin and SUMO.  Several 
proteins that are mutated in familial forms of ALS are targets of SUMO, and SUMO 
appears to be an important regulator for several proteins directly involved in the 
mechanisms underlying ALS (19).  The hypoxic response is partially mediated by 
hypoxia inducible factor (HIF1), the sumoylation of which promotes its translocation to 
the nucleus, while the oxidative stress response involves desumoylation of another 
protein, p300, which then binds with HIF1 (19).  
Misfolded proteins are also the cause of spinocerebellar ataxia, a polyQ disease, 
which involves a mutated and misfolded form of ataxin1 (3).  The promyelocytic 
leukemia protein (PML) interacts with misfolded proteins in the nucleus and conjugates 
them with SUMO, which then attracts RNF4 and targets the proteins to proteasomal 
degradation (11).  Deficiency in PML prevents sumoylation of ataxin1 and exacerbates 
pathological phenotypes in a mouse model of spinocerebellar ataxia (11).  Overall, 
many human pathogenic diseases are caused by cellular stress, particularly protein 
misfolding stress, making the study of these cellular processes an important pursuit. 
1.4 Rationale for Study 
Much research has been done on the role of SUMO in protein misfolding stress, 
but there is a lack of information on the molecular mechanisms by which  SUMO 
protects the cell from stress-induced damage.  A large scale mutagenesis project has 
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been undertaken to investigate which residues on SUMO are required for its role in 
various cell stress responses (Newman H, unpublished) (Figure 2).  These studies led to 
the identification of a mutant form of SUMO, containing lysine to alanine substitutions 
at residues 38 and 40, which sensitizes yeast to various stresses including protein 
misfolding.  We investigated how mutations in these two residues affect the role of 
SUMO in the protein misfolding stress response using a high-copy suppressor screen.  
We hypothesized that the resulting suppressor proteins would reveal insights into the 
molecular mechanisms by which sumoylation protects cells from toxic misfolded 
proteins. 
Figure 2:  Mutagenesis Project.  Heat map displaying sensitivity of var ious str ains 
from mutagenesis project. 
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2. Materials and Methods 
2.1 Methods 
ATP Depletion and Recovery 
Cells were grown overnight to saturation in the appropriate synthetic media at 30°C.  
The cells were diluted to OD600 0.25 in synthetic media the following day and were 
allowed to grow to OD600 0.8.  One milliliter of cells was added to each tube and spun at 
5,000 rpm for 2 minutes.  The cells were then washed in 1 mL of fresh media, pelleted, 
then resuspended in 1 mL of fresh media.  One sample was harvested and the pellet was 
frozen in liquid nitrogen as the starting sample.  The remaining tubes of cells were 
washed with 1X PBS, harvested, then resuspended in 1 mL of ATP depletion solution 
(10 mM sodium azide, 10 mM 2-deoxyglucose in PBS). Cells were incubated in the 
ATP depletion solution at 30°C for 2, 4, or 8 minutes.  Cells were then pelleted and 
frozen in liquid nitrogen.  The remaining cells were washed once with 1 mL of 1X PBS, 
harvested, and resuspended in 1 mL of synthetic medium.  Cells were allowed to 
recover at 30°C for 2 or 4 minutes.  Following recovery, the cells were pelleted and 
frozen in liquid nitrogen. 
Yeast Protein Extract 
Cell pellets were resuspended in 200 μL of 20% TCA and 100 μL of acid-washed glass 
beads then vortexed for 8 minutes at 4°C.  One milliliter of 5% TCA was added to each 
sample followed by incubation on ice for 10 minutes.  One milliliter of each sample was 
transferred to a preweighed tube and centrifuged at 13,000 rpm for 5 minutes.  The 
supernatant was removed and the tubes were reweighed to get the sample weight.  
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Pellets were resuspended in sample buffer (125 mM Tris-Cl ph 6.8, 4% SDS, 20% 
Glycerol, 10% beta-mercaptoethanol, 0.05% bromophenol blue, and 0.02 μL 2M Tris 
Base/μL) to a standardized concentration, then boiled for 5 minutes and centrifuged for 
5 minutes at 13,000 rpm. 
Western Blotting 
Five microliters of each whole cell lysate was loaded onto a 12.5% SDS-PAGE gel.  
The gel was run at 200V for 40 minutes, and the protein was transferred onto a 
nitrocellulose membrane at 100V for 2 hours.  The membrane was blocked with 5% 
milk with Tween overnight, then treated with primary antibody (αSUMO or αtubulin in 
2% BSA in 1X PBS) for one hour.  After 30 minutes of washing with Tween+ST 
(0.05% Tween in 50mM Tris-Cl pH7.6 and 140 mM NaCl), the membrane was treated 
with secondary antibody (αrabbit in 2% BSA in 1X PBS) for one hour.  After washing, 
the membrane was treated with ECL from Amersham according to the manufacturer’s 
protocol.  Signal was detected through film exposure and development 
Yeast Transformation 
Yeast culture(s) of OD600 0.4-0.8 were spun down in 1-2 mL aliquots at 5000rpm for 2 
minutes.  Cells were washed twice with 1 mL of 0.1 M LiOAc, then resuspended in 250 
μL of 0.1 M LiOAc.  A mixture of 620 μL 50% PEG, 90 μL 1M LiOAc and 10 μL 
ssDNA (40 μL for high efficiency transformations) was added to the cells along with the 
transformation DNA.  Tubes were inverted gently to mix, then incubated at 30°C for 40 
minutes, mixing by inversion every 10 minutes.  100 μL DMSO was added and cells 
were incubated at 42°C for 20 minutes, mixing every 10 minutes.  Tubes were spun 
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down at 5000 rpm for 2 minutes and washed once with 5mM CaCl2.  Cells were 
resuspended in 150 μL CaCl2 and plated on SC-Ura-Arg plates (SC-Ura-Arg+Can 1ug/
mL for initial screening). 
Yeast Plasmid Miniprep 
Plasmids were isolated using the Qiagen miniprep kit (catalog #27106).  2-5mL of cells 
were harvested by centrifugation at 2000 rpm and resuspended in 250 μL Buffer P1 
containing 0.1 mg/mL RNase A.  50-100uL of acid washed glass beads were added to 
the cells and the sample was vortexed for 5 minutes in 4°C room.  The supernatant was 
transferred to a fresh microcentrifuge tube.  250 μL lysis buffer was added and the tube 
was inverted gently 4-6 times to mix, then incubated at room temperature for 5 minutes.  
350 μL of neutralization buffer was added and the tube was inverted immediately but 
gently 4-6 times.  The tube was then centrifuged 10 minutes at 14,000 rpm.  Lysate was 
transferred to a spin column, then centrifuged 1 minute at 14,000 rpm, discarding flow 
through.  750 mL wash buffer was added and centrifuged for 1 minute.  Flow through 
was discarded and the tube was centrifuged for one additional minute. The spin column 
was placed in a microcentrifuge tube and 25 μL elution buffer was added.  The tube was 
left to stand for 1 minute, then centrifuged 1 minute. 
5FOA Assay 
Putative suppressor colonies were patched onto plates containing 0.1% 5-fluoroorocetic 
acid and grown for two days.  Remaining colonies no longer contained the library 
plasmids with the URA3 marker.  Once the colonies no longer contained plasmids, they 
were again tested for resistance to canavanine.  Colonies resistant to canavanine after 
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this test were discarded as their resistance did not come from overexpression of a yeast 
gene but rather a mutation in the genome. 
E. coli Transformation 
Competent DH5α cells were thawed in hand and placed on ice for 10 minutes.  DNA 
was added to each tube and the tubes incubated on ice for 30 minutes.  Tubes were heat 
shocked at 42°C for 1 minute, then placed back on ice for 2 minutes.  800 μL of 1X 
SOC (Super Optimal Broth with catabolite repression) was added and the tubes were 
shaken at 37°C for 1 hour.  Cells were plated on LB plates containing 100 μg/mL of 
carbenicillin and grown at 37°C overnight. 
E. coli Plasmid Miniprep 
ThermoScientific GeneJET plasmid miniprep kit (Life Technologies, catalog #K0503) 
was used for all minipreps out of E. coli. 
2.2 Materials 
Dropout Mix: 0.5g Adenine, 2.0g Alanine, 2.0g Asparagine, 2.0g Aspar tic acid, 2.0g 
Cysteine, 2.0g Glutamine, 2.0g Glutamic acid, 2.0g Glycine, 2.0g Histidine, 2.0g 
Inositol, 2.0g Isoleucine, 10.0g Leucine, 2.0g Lysine, 2.0g Methionine, 0.2g para-
Aminobenzoic acid, 2.0g Phenylalanine, 2.0g Proline, 2.0g Serine, 2.0g Threonine, 2.0g 
Tryptophan, 2.0g Valine  
Synthetic Complete Media: 2.0g Dr opout Mix, 6.67g Yeast Nitr ogen Base without 
Amino acids, 2% Glucose, 1L H2O; for plate media include 20g Agar per liter. 
ATP Depletion Solution: 10 mM sodium azide, 10 mM 2-deoxyglucose in 1X PBS. 
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Plasmids: All tr ansfor mation were done using the PJEF2626 vector , a high-copy 
yeast expression vector containing an E. coli replication site, carbenicillin resistance 
gene, and URA3 marker.   
For the 2-hybrid assay, genes tested for interaction were cloned into plasmids containing 
a Gal4 promotor and either an activating domain (AD) or a binding domain (BD). 
The yeast genomic library was obtained from Dr. Pamela Meluh. 
Cloning work was carried out in the PGEMT-EZ vector according to manufacturer’s 
protocol, followed by restriction enzyme digest and insertion into PJEF2626. 
San1 Cloning Primer Pairs: 
 
San1 Region Primer Pairs 
Promotor (P) Forward: ATGCGGTACCAGGACACAATCTGAATCCTCCA 
Reverse: ATGCGTCGACAATGAACAAAAGCTGAGGTTACA 






























3.1 SUMO K38/40A double mutant is sensitive to canavanine 
To study the role of SUMO in stress response, a library of SUMO mutants was 
generated in which each mutant either had one residue mutated to alanine or multiple 
residue changes.  The library was integrated into yeast and resulting strains were 
screened for sensitivity to various stress conditions (Newman H, unpublished).  As this 
study is focused on protein folding stress, we screened the collection for strains sensitive 
to canavanine, an arginine analog that induces misfolding when incorporated into 
proteins.  From this screening, we identified one mutant in which the lysines at positions 
38 and 40 were mutated to alanine (K38/40A) which was particularly sensitive to 
growth in the presence of canavanine.  The locations of K38 and K40 in SUMO are 
shown in Figure 3A.  To demonstrate that the canavanine sensitivity of the K38/40A 
mutant was due to the mutations in SUMO, I transformed wildtype and mutant cells 
with a vector containing the yeast isoform of SUMO, SMT3,  and performed a spotting 
assay on plates containing 1 μg/mL of canavanine.  Cells were also transformed with an 
empty vector for a negative control (Figure 3B).  The mutant strain transformed with the 
SMT3 grew equally well as wildtype transformants, while the mutant transformed with 
an empty vector did not grow as well.   This confirms that the deficiency in the 
K38/40A SUMO mutant strain is caused by defective SUMO and not some other 
factors. 
3.2 Characterization of SUMO levels and conjugation in K38/40A mutant 
Since previous studies have shown canavanine treatment to induce sumoylation 
(21), we next looked at the profile of sumoylation in both mutant and wildtype strains.  
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Figure 3.  SUMO K38/40A Mutant Sensitivity to Canavanine.  A. Structure of 
SUMO with mutated residues indicated in yellow.  B. Wildtype and K38/40A strains 






Whole cell lysates of mutant and wildtype strains with and without canavanine 
treatment were probed for SUMO (Figure 4A).  Overall, both strains showed an increase 
in high molecular weight conjugates under canavanine treatment.  The mutant strain 
seemed to show a greater increase in high molecular weight conjugates, however there 
was not a corresponding decrease in free SUMO levels.   
Since the sumoylation levels were not different between mutant and wildtype 
strains, we also wanted to characterize the conjugation and deconjugation efficiency of 
SUMO in mutant and wildtype strains.  In the very dynamic sumoylation cycle, SUMO 
conjugation is ATP dependent but deconjugation is not, therefore we performed an ATP 
depletion and recovery assay.  Mutant and wildtype cells grown to log phase in synthetic 
complete media were resuspended in ATP depletion media for 0, 2, 4, or 8 minutes.  
After an 8 minute depletion, cells were allowed to recover in synthetic complete media 
for 2 or 4 minutes.  Cells were pelleted immediately after treatment and whole cell 
lysates were probed for SUMO protein levels (Figure 4B).  SUMO conjugation levels 
decreased with similar kinetics in both mutant and wildtype strains.  However, nearly 
complete recovery of sumoylation was observed in the wildtype strain within 2 minutes 
of ATP restoration, while the mutant had not fully recovered even after 4 minutes.  
3.3 Interaction between K38/40A mutant and downstream SIM-containing 
proteins 
The lower than normal levels of free SUMO observed in the K38/40A mutant 
strain, along with the apparently reduced conjugation efficiency could potentially 
explain the observed canavanine sensitivity of this strain.  To test this hypothesis, we 
overexpressed the K38/40A on a high-copy expression vector in the mutant strain and 
14 
 
Figure 4: Sumoylation levels and ATP Depletion Assay.  A.  Wildtype and mutant 
strains were treated with 0 or 60 μg/mL of canavanine for 2 hours.  Whole cell lysates 
were probed for SUMO, with tubulin as a loading control.  B. Mutant and wildtype 
strains were depleted of ATP for 0, 2, 4, or 8 minutes.  After 8 minutes of depletion, 2 or 
4 minutes of recovery were allowed.  Whole cell lysates were probed for SUMO, with 
tubulin as a loading control. 
performed a spotting assay.  The overexpression restored sumoylation levels to near 
wildtype, but did not suppress canavanine sensitivity (Lu J, unpublished), thus 
indicating that reduced SUMO expression and conjugation could not alone explain the 
phenotype.   
K38 and K40 are positioned on a surface of SUMO involved in interactions with 




Figure 5: SLX5/8 Suppression and Binding Assay.  A.  A two-hybrid assay was 
performed with SMT3 or K38/40A and SLX5 or SLX5 with a SIM mutation (SLX5*).  
Strains were plated on SC-Leu-Trp as a control and SC-Leu-Trp-Ade to determine 
interaction.  B. A high-copy plasmid containing SLX5/8 was transformed into the 
K38/40A strain and tested on canavanine with SMT3 as a positive control and an empty 





mutant may be deficient in interactions with SIM-containing effector proteins 
functioning downstream of SUMO conjugation.  To examine interactions of the 
K38/40A mutant with such proteins, we investigated the interactions of the mutant with 
Slx5/8, a SUMO-targeted ubiquitin E3 ligase (22, 23).  Slx5/8 is a heterodimer in which 
Slx5 contains a tandem SIMs that bind tightly to polymeric SUMO and Slx8 contains a 
catalytic RING domain.  A two-hybrid assay was performed with wildtype and 
K38/40A mutant SUMO and wildtype Slx5 or a SIM-defective Slx5 mutant (Slx5*).  As 
expected, strains expressing Slx5* showed no interaction with either wildtype or mutant 
SUMO, highlighting the importance of the SIM for SUMO binding.  When examining 
interactions with wildtype Slx5, we observed much weaker interactions with the 
K38/40A mutant compared to wildtype SUMO, indicating that the mutations do affect 
SIM binding as hypothesized  (Figure 5A).   
Because the K38/40A mutant SUMO has reduced affinity for Slx5, we 
hypothesized that overexpression of Slx5 may suppress the canavanine sensitivity of the 
K38/40A mutant strain.  To test this, I expressed the SLX5 and SLX8 genes together on 
a high-copy vector in the mutant strain and performed a spotting assay on plates 
containing 1 μg/mL of canavanine.  As hypothesized,  the Slx5/8 complex suppressed  
sensitivity to canavanine (Figure 5B).  Taken together, our findings demonstrate that the 
K38/40A  SUMO mutant is deficient in binding to Slx5 and likely to other SIM-
containing proteins.  Moreover, our findings also indicate that the Slx5/8 SUMO-
targeted E3 ligase is an important downstream effector of sumoylation and its role in 
protein misfolding.  The SLX5/8 overexpression assay also establishes the feasibility of 
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Figure 6: Experimental Design and Screening Experiments.  A. After  initial 
identification of suppressors, a secondary screening was performed.  Suppressors falling 
into each category indicated with parentheses.  Plasmids were retransformed to confirm 
suppression (B) and then treated with 5FOA and retested for canavanine resistance (C).  
Plasmids were sequenced and cutbacks were performed with restriction enzymes to 
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a high-copy suppressor screen to identify downstream targets of SUMO that are affected 
by the K38/40A mutation. 
3.4 High copy suppression screen in K38/40A mutant 
The ability to suppress the canavanine sensitivity of the K38/40A mutant strain 
with Slx5/8 overexpression suggested that an unbiased high copy suppressor screen 
could be used to find other downstream effectors of SUMO.  To examine this, I 
transformed a  library of yeast genomic DNA on a high-copy URA3 vector into the 
K38/40A mutant and grew the cells onto SC-Ura-Arg plates containing 1 μg/mL of 
canavanine.  One control plate (SC-Ura-Arg without canavanine) was used to determine 
genome coverage for the transformation.  I calculated that the genome was covered 
approximately 5 times based on the number of transformants on the control plate.  From 
the canavanine plates I initially identified 32 colonies as suppressors based on colony 
size after two days of growth.  Plasmids obtained from these suppressors were then 
subjected to secondary screening (Figure 6A), which included retransformation and 
growth on canavanine and a 5FOA sensitivity assay (Figure 6B and C).  This screening 
removed 10 plasmids that did not show plasmid-specific suppression after being 
transformed back into the mutant strain and tested for suppression after 5FOA-induced 
loss of plasmid.  The remaining 22 plasmids were sequenced and subjected to cutback 
experiments in order to determine the segments of the yeast genome responsible for 
Figure 7 (Next Page): Suppression of Wildtype Sensitivity.  (A). Two suppressor s, 
LDB19 and GZF3, were transformed into the wildtype strain to test general suppression 
of canavanine sensitivity.  (B). GZF3 was transformed into the WT strain and  RT-PCR 








conferring suppression to the K38/40A mutant.  As an example, Figure 6D shows one 
suppressor (Sup02) that contained three genes: PMT3, LDB19, and PRO2.    I 
transformed cutback plasmids as well as the original suppressor into the mutant strain 
and performed a spotting assay on plates containing 1 μg/mL of canavanine (Figure 6E).  
Neither cutback suppressed K38/40A sensitivity, indicating that LDB19 represents the 
suppressor gene.  This approach was repeated and of the 22 suppressor plasmids, seven 
were found to suppress through LDB19, three through GZF3, four through ECM21, 
three through SAN1 and five through SMT3.   
3.5 SUMO-independent suppression of canavanine sensitivity 
Ldb19 and Ecm21 are regulators of endocytosis (24) while GZF3 is a 
transcriptional regulator (25), and all three of these genes are involved in the regulation 
or turnover of the canavanine transporter Can1.  We therefore hypothesized that high 
copy expression of these genes could confer canavanine resistance by reducing levels of 
Can1 transporter at the plasma membrane.  If true, these genes would be predicted to 
suppress canavanine sensitivity in wildtype strain as well as the K38/40A SUMO 
mutant strain.  To test this prediction, I transformed one of the endocytosis regulators, 
LDB19, and the transcriptional regulator, GZF3, into wildtype cells and performed a 
spotting assay on plates containing 2 and 4 μg/mL of canavanine (Figure 7A).  Strains 
carrying high-copy LDB19 or GZF3 grew better than those carrying SMT3 or empty 
vector on canavanine plates, which is consistent with the prediction that these genes are 
affecting Can1 independently of SUMO.   
GZF3 is a transcription factor that negatively regulates expression of the CAN1 
gene (26). We performed an RT-PCR experiment in order to examine the effect of 
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Figure 8: San1 Suppression. A. Diagram of SAN1 protein domains, including 
unstructured N- and C-termini and a catalytic RING domain.  * Denotes NLS.  B. SAN1 
mutants were made in the catalytic RING domain and tested for their ability to suppress 
canavanine sensitivity. C. SAN1 constructs were transformed into K38/40A strain and 






GZF3 overexpression on the expression levels of the CAN1 in the presence or absence 
of canavanine (Figure 7B).  As expected, strains transformed with a high-copy GZF3 
vector showed increased GZF3 expression levels and decreased CAN1 expression 
levels.  Treatment with canavanine had no noticeable effect on the expression levels of 
either gene, and ACT1 expression levels were constant across all strains.  These results 
demonstrate that GZF3 suppresses canavanine sensitivity in a SUMO-independent 
manner by affecting CAN1 expression and canavanine import. 
3.6 San1 N-terminus suppresses K38/40A sensitivity to canavanine 
Having excluded LDB19, ECM21, and GZF3 as general suppressors, we next 
turned our focus to SAN1, a gene that encodes a ubiquitin E3-ligase and whose 
suppressing activity was specific to our K38/40A mutant (data not shown).  San1 is of 
particular interest because it has been implicated in protein quality control in the 
nucleus (27).  San1 has three distinct domains, including a catalytic RING domain 
containing a nuclear localization signal (NLS) and unstructured N- and C-termini (27) 
(Figure 8A).  While the catalytic domain facilitates ubiquitylation of protein substrates, 
the unstructured termini function to recognize and bind unfolded and unstructured 
regions of proteins.  Of the three original SAN1-containing plasmids found in our 
suppressor screen, two contained the full-length SAN1 gene while one contained a 
partial gene encoding for the N-terminal region, the RING domain, and only part of the 
C-terminal region (Figure 8A).  Each of the three plasmids conferred approximately 
equivalent resistance to canavanine, which indicates that the C-terminus is not required 
for suppressor function. 
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  To explore whether or not the RING E3 ligase activity was required for 
suppression, I transformed three catalytic mutants of SAN1 (R280A, C165A, and 
W269A) into the mutant strain along with a C-terminal truncation mutant and a full-
length version and performed a spotting assay on plates containing 1 μg/mL of 
canavanine (Figure 8B).  All of the catalytic mutants and the C-terminal truncation 
mutant San1 grew equally well on the canavanine plates, showing that the ubiquitin E3 
ligase activity of San1 is not required for suppressing canavanine sensitivity.  
To further define the domains of SAN1 that are responsible for suppressing the 
mutant sensitivity to canavanine, I generated four constructs with different combinations 
of the RING domain and the N- and C-termini (Figure 8A).  I then transformed these 
four constructs into the K38/40A strain and performed a spotting assay on plates 
containing 1 μg/mL of canavanine (Figure 8C).  While constructs lacking the N-
terminus failed to suppress the mutant sensitivity, each of the constructs with the N-
terminus conferred resistance to canavanine.  This demonstrates that the N-terminus of 
San1 is both necessary and sufficient for the suppression of the K38/40A mutant 




 Protein quality control is a vital cellular process: misfolded proteins are the 
cause of many human diseases including cystic fibrosis (17, 18), Parkinson’s disease 
(20), Alzheimer’s disease, and other neurodegenerative diseases (3).  The 
posttranslational modifier SUMO is known to be involved in protein quality control in 
the nucleus (28).  It is thought that PML recognizes and attaches SUMO to misfolded 
proteins, which allows the proteins to be tagged with ubiquitin by RNF4 and marked for 
degradation (10, 29).  In this capacity, RNF4 operates as a SUMO-targeted ubiquitin 
ligase (STUbL), a class of ubiquitin E3 ligases that recognize SUMO-tagged proteins 
that need to be degraded by the proteasome (30, 31). 
 Here we investigate a mutant form of SUMO with lysines at residues 38 and 40 
changed to alanines.  These mutations occur in the SIM-binding domain of SUMO and 
cause a particular sensitivity to drugs that induce protein misfolding (Figure 3).  This 
sensitivity is influenced by reduced affinity of the mutant  to the SUMO-interacting 
motif of substrates (Figure 4, 5).  In a successful high-copy suppressor screen, we were 
able to identify four suppressors of canavanine sensitivity along with wildtype SMT3.  
As all four suppressor genes and SMT3 were found a minimum of three times (Figure 
7A), we appear to have saturated the suppressors that can be found from this genomic 
library. 
 The K38/40A mutant-specific sensitivity to canavanine can be suppressed by the 
overexpression of San1 (Figure 8), a ubiquitin E3 ligase that localizes to the nucleus and 
specifically targets aberrant proteins for degradation (27).  While previous studies have 
shown that San1 requires its catalytic domain and NLS for proper function (27), our 
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results show that the N-terminus is necessary and sufficient for suppression of the 
SUMO K38/40A mutant sensitivity to canavanine (Figure 8C).  Preliminary data from a 
two-hybrid assay suggests that full-length San1 does not interact with wildtype or 
mutant SUMO, which would rule out the idea that San1 sequesters SUMO or SUMO-
modified proteins.  Instead, we hypothesize that San1 is compensating for reduced 
levels of sumoylation on misfolded proteins and therefore decreased activity of 
STUbLs.  Given that the N-terminus of San1 has no known NLS, this seems to indicate 
that it is operating in the cytoplasm when suppressing canavanine sensitivity.  Neither 
SUMO nor San1 is known to affect protein quality control outside of the nucleus.  If the 
N-terminus of San1 can be verified as localizing to the cytoplasm, this would open 
interesting research questions into the function of San1 and SUMO in protein quality 
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